Tixagevimab and Cilgavimab Injection, 300 mg

California rates for HCPCS Q0220

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known SARS-CoV-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available COVID-19 vaccine is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s), 300 mg

Rates data updated October 2026.

How much rates vary

Professionalmedian $0 · 10th to 90th $0 to $407

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High
Kaiser Permanente Setting Professional Modifier None Typical Low $407.38 Median $407.38 Typical High $407.38	Professional	None	$407.38	$407.38	$407.38
United Setting Professional Modifier None Typical Low $0.02 Median $0.02 Typical High $0.02	Professional	None	$0.02	$0.02	$0.02